Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

bio-T

Financiado

Cerrado

Enabling medical device vendors to realize the potential of the data collectible...

Enabling medical device vendors to realize the potential of the data collectible by their devices The Internet of Medical things (IoMT), a multi hundred billion Euro market by 2028, presents an opportunity to revolutionize healthcare by collecting and analysing real time patient data. The IoMT brings together the digital and p... ver más

29/02/2020

Softimize

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

SOFTIMIZE LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-02-29

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Softimize

50.00K€ | Lider

BIOSEGURIDAD Y ANALISIS INMU...

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CYLCOMED Cyber securitY tooLbox for COnnected MEdical Devices 3M€ Cerrado

SEPTON SECURITY PROTECTION TOOLS FOR NETWORKED MEDICAL DEVICES 5M€ Cerrado

SERUMS Securing Medical Data in Smart Patient Centric Healthcare Sy... 4M€ Cerrado

MEDSECURANCE Advanced Security-for-safety Assurance for Medical Device Io... 5M€ Cerrado

SPHINX A Universal Cyber Security Toolkit for Health Care Industry 5M€ Cerrado

AGENTES REMOTOS VIRTUALES PARA PUNTOS DE SOPO... AGENTES REMOTOS VIRTUALES PARA PUNTOS DE SOPORTE DE DISPOSIT... 221K€ Cerrado

Duración del proyecto: 3 meses Fecha Inicio: 2019-11-06
Fecha Fin: 2020-02-29

Líder del proyecto

SOFTIMIZE LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The Internet of Medical things (IoMT), a multi hundred billion Euro market by 2028, presents an opportunity to revolutionize healthcare by collecting and analysing real time patient data. The IoMT brings together the digital and physical worlds to improve the speed and accuracy of diagnosis and treatments, and monitor and modify patient behaviour and health status in real time. It improves health care organisations’ operational productivity and effectiveness by streamlining clinical processes, information and work flows. Therefore medical device companies need to transform into data companies. BUT IoMT is inherently complex, and vendors face Major skill and technology gaps they must overcome in areas such as cyber security, Data Privacy and Quality regulations as well as scaling IoMT solutions to support Millions of devices worldwide. The bio-T™ platform is HIPAA & GDPR compliant, designed specifically for connected medical devices with the aim of reducing risk and saving valuable time, money and focus for healthcare innovators. The bio-T™ platform is an IoMT specific solution built to be flexible, secure, and cloud-agnostic, saving innovators the need to reinvent the wheel for their own device. Designed to provide complete flexibility and data ownership, the bio-T™ platform is a software allowing quick and affordable device connectivity and healthcare-related functions, including adherence management, remote patient monitoring, regulation compliance (US FDA & HIPAA, EU ISO & GDPR), and verification and validation protocols. bio-T is home for expert IoT, cloud and mobile app engineers, and has years of experience developing outstanding solutions for connected healthcare products. The IoMT market is expected to grow at a compound annual growth rate (CAGR) of 30.8 per cent, from €37 billion in 2017 to €158 billion by 2022. The tens of thousands of companies worldwide represent a €9b market size for bio-T.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores